Your browser doesn't support javascript.
loading
Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial.
Baten, E; Van Der Aa, F; Goethuys, H; Slabbaert, K; Arijs, I; van Renterghem, K.
Afiliação
  • Baten E; Associatie Urologie Hageland, Tielt-Winge, Belgium.
  • Van Der Aa F; U Hasselt, Hasselt, Belgium.
  • Goethuys H; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Slabbaert K; Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Arijs I; Associatie Urologie Hageland, Tielt-Winge, Belgium.
  • van Renterghem K; Center for Cancer Biology, Leuven, Belgium.
J Urol ; 205(6): 1748-1754, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33560163
ABSTRACT

PURPOSE:

We sought to determine whether omitting antimicrobial prophylaxis is safe in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative catheter. MATERIALS AND

METHODS:

We conducted a multicenter randomized controlled trial from September 17, 2017 until December 31, 2019 in 5 hospitals. Patients with pyuria (>100 white blood cells/ml) and a preoperative indwelling catheter were excluded. Postoperative fever was defined as a body temperature ≥38.3C. A noninferiority design was used with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0 C (antimicrobial prophylaxis group) - E (no antimicrobial prophylaxis group) ≥ Δ (6% noninferiority margin). A multivariable, logistic regression was performed regarding posttransurethral resection of the prostate fever and antimicrobial prophylaxis with co-variates (clot-)retention and operating time. The R Project® for statistical computing was used and a p value of 0.05 was considered as statistically significant.

RESULTS:

Of the patients 474 were included for multivariable analysis and 211/474 (44.5%) received antimicrobial prophylaxis vs 263/474 (55.5%) patients without antimicrobial prophylaxis. Antibiotics were fluoroquinolones in 140/211 (66.4%), cephazolin in 58/211 (27.5%) and amikacin in 13/211 (6.2%) patients. Fever occurred in 9/211 (4.4%) patients with antimicrobial prophylaxis vs 13/263 (4.9%) without antimicrobial prophylaxis (p=0.8, risk difference 0.006 [95% CI -0.003-0.06, relative risk 1.16]). We were able to exclude a meaningful increase in harm associated with omitting antimicrobial prophylaxis (p=0.4; adjusted risk difference 0.016 [95% CI -0.02-0.05]).

CONCLUSIONS:

Our data demonstrate the safety of omitting antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative indwelling catheter.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Infecções Urinárias / Amicacina / Cefazolina / Antibioticoprofilaxia / Ressecção Transuretral da Próstata / Fluoroquinolonas / Antibacterianos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Infecções Urinárias / Amicacina / Cefazolina / Antibioticoprofilaxia / Ressecção Transuretral da Próstata / Fluoroquinolonas / Antibacterianos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica